Clin2
NCT06518317Worth exploringRecruiting

Short vs Long Blood Thinner Use After TAVI

Transcatheter Aortic Valve Replacement

Treatments studied

Part of Heart & circulation clinical trials.

This trial compares a short course versus a longer course of antiplatelet medicine (blood thinners) after a TAVI procedure for aortic stenosis. It aims to see which approach is safer and more effective.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,400 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You had a successful TAVI procedure for aortic stenosis through a leg artery.
  • You are 18 years old or older.
  • You do not need long-term blood thinners for other heart or blood vessel conditions.
  • You are not on any anticoagulant (like warfarin) for conditions such as atrial fibrillation.
  • You speak French and have French social security.
  • Women: You must be past menopause (no period for 12 months) or surgically sterilized.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05687448Not yet recruiting· Phase 3
Comparing blood thinners after aortic valve replacement

This trial compares two blood-thinning treatments after aortic valve replacement with a tissue valve. It tests if a convenient pill (apixaban) is as safe and effective as aspirin alone, to prevent blood clots and other complications. Participation could help improve recovery and reduce the risk of strokes and bleeding.

Paris, Paris
NCT07164859Not yet recruiting· Phase 3
Shorter blood thinner use after heart stents in older adults

This study tests whether a shorter course of blood-thinning medication after heart stent placement is safer and just as effective for older adults. It aims to reduce bleeding risks while still preventing heart attacks and strokes.

Caen
NCT07512960Recruiting· Phase 3
Blood Thinner Duration After Leg Artery Treatment

This trial tests how long patients should take two blood-thinning medications (aspirin and clopidogrel) after treatment to restore blood flow to a severely damaged leg. The goal is to find the right balance between preventing clots and avoiding dangerous bleeding.

Paris, Île-de-France Region
NCT06007222Recruiting· Phase 4
No blood thinners after TAVI: a trial for heart valve patients

This trial is for people who have had a TAVI procedure to replace a narrowed heart valve, and it tests whether it is safe to skip blood thinners afterward. The goal is to find the best way to protect your health without unnecessary medication.

Shinjuku, Tokyo
NCT06168370Recruiting
Personalized blood thinners after TAVI vs. standard care

This trial tests whether a personalized plan for blood thinners after TAVI can reduce the risk of stroke or bleeding better than the current standard of one daily blood thinner. If you've had a successful TAVI and don't need specific other blood thinners, you might be able to join.

Nieuwegein
NCT05493657Recruiting
Aspirin vs clopidogrel after TAVR valve procedure

This trial compares aspirin and clopidogrel (two blood-thinning medicines) after TAVR to see which is safer or more effective for preventing clots. You may be able to join if you recently had a TAVR for severe aortic valve narrowing and can follow the study plan.

Seoul

Hear when a new Transcatheter Aortic Valve Replacement trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.